Can Whole-Blood Samples Be Stored over 24 Hours Without Compromising Stability of C-Reactive Protein, Retinol, Ferritin, Folic Acid, And Fatty Acids in Epidemiologic Research?(Technical Briefs) (Clinical Report) Can Whole-Blood Samples Be Stored over 24 Hours Without Compromising Stability of C-Reactive Protein, Retinol, Ferritin, Folic Acid, And Fatty Acids in Epidemiologic Research?(Technical Briefs) (Clinical Report)

Can Whole-Blood Samples Be Stored over 24 Hours Without Compromising Stability of C-Reactive Protein, Retinol, Ferritin, Folic Acid, And Fatty Acids in Epidemiologic Research?(Technical Briefs) (Clinical Report‪)‬

Clinical Chemistry 2005, Jan, 51, 1

    • CHF 3.00
    • CHF 3.00

Publisher Description

Ideally, blood samples for biomarker measurement are collected centrally and processed immediately to avoid any unwanted changes in concentrations that could affect validity. In large-scale epidemiologic and clinical studies, however, this theoretical goal must give way to a more pragmatic approach (1, 2). The Amsterdam Born Children and their Development (ABCD) study is a clinically based cohort study of pregnant women in Amsterdam (The Netherlands) in which we use, for practical and ethical reasons, blood collection in conjunction with existing schemes of care, with samples subsequently sent to a central laboratory by mail or courier. As a consequence, delay times between collection and processing may exceed 24 h, to an incidental maximum of 96 h. Although the stabilities of the biomarkers of interest, i.e., C-reactive protein (CRP), retinol, ferritin, folic acid, and fatty acids (FAs), have been studied previously (1-9), the variety of designs (e.g., storage [less than or equal to] 24 h) hampers the applicability of existing results to our research and similar studies. We therefore investigated the appropriateness of our standardized, practice-based approach of blood collection by assessing stability in samples stored up to 96 h (the maximum delay time possible when samples are sent by mail) with a focus on the first 28 h (the maximum delay time allowed in the ABCD study). Blood samples were collected from 41 generally healthy female volunteers, 22-56 years of age. One woman was at that time 16 weeks pregnant, but because her measurements did not deviate, we decided not to exclude her from analysis. Written informed consent was obtained from all participants. For 20 women, 28 mL of blood was collected in seven 4-mL Vacuettes (Greiner BV) for the preparation of serum. For the other 21 women, 28 mL of blood was collected in seven 4-mL Vacutainer EDTA tubes (Becton and Dickinson BV) for the preparation of plasma. One tube from each woman was centrifuged (1600g for 10 min) between 1 and 2 h after blood collection (to; baseline), and the remaining tubes were stored in a cabinet at room temperature (~21[degrees]C) and centrifuged 2 ([t.sub.2]), 4 ([t.sub.4]), 24 ([t.sub.24]), 26 ([t.sub.26]), 28 ([t.sub.28]), or 96 ([t.sub.96]) h after baseline. Time points were chosen to mimic courier and postal conditions seen in the ABCD study, 4 h being the anticipated maximum delay time when blood is sent by courier, 28 h being the anticipated maximum delay time when blood is sent by overnight mail, and 96 h being the anticipated maximum delay time when blood is sent by mail but over the weekend.

GENRE
Science & Nature
RELEASED
2005
1 January
LANGUAGE
EN
English
LENGTH
12
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
SIZE
315.7
KB

More Books by Clinical Chemistry

The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments (Special Report) (Polymerase Chain Reaction) (Report) The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments (Special Report) (Polymerase Chain Reaction) (Report)
2009
D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report) D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report)
2004
Congenital Analbuminemia Attributable to Compound Heterozygosity for Novel Mutations in the Albumin Gene (Technical Briefs) Congenital Analbuminemia Attributable to Compound Heterozygosity for Novel Mutations in the Albumin Gene (Technical Briefs)
2005
Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs) Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs)
2005
Measurement of Pro-C-Type Natriuretic Peptide in Plasma (Technical Briefs) Measurement of Pro-C-Type Natriuretic Peptide in Plasma (Technical Briefs)
2005
Newborn Screening for Lysosomal Storage Disorders (Editorials) Newborn Screening for Lysosomal Storage Disorders (Editorials)
2005